# Zenas BioPharma’s Phase 3 autoimmune disease readout falls short, sending shares plummeting

**Source:** Endpoints News
**URL:** https://e.endpointsnews.com/t/t-l-wpmit-jykykhhuld-k/
**Date:** 2026-01-06

---

January 5, 2026 11:21 AM EST R&DFDA+

Lei Lei Wu

News Reporter

Zenas Bio­Phar­ma said its ex­per­i­men­tal an­ti­body suc­ceed­ed in a piv­otal study for IgG4-re­lat­ed dis­ease, an au­toim­mune con­di­tion, and that it plans to seek FDA ap­proval …

---

#news #endpoints-news
